Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 7:47 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 193–216 of 3,459 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Metabolic Effects Clear all

Conditions: Metabolic Syndrome
Interventions: Sugary beverage: Fruit juice, Sugary beverage: Soda, Control: Water; Dietary Supplement
Lead sponsor: Kansas State University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Manhattan, Kansas

Conditions: Hepatitis C
Interventions: Elbasvir/grazoprevir; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Obesity or Overweight
Interventions: AZD5004, Placebo; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years and older
Enrollment: 310 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 30
States / cities: Chandler, Arizona • Huntington Park, California • La Mesa, California + 27 more

Conditions: Hyperlipidemia, HIV Infections
Interventions: L-carnitine, placebo; Dietary Supplement · Other
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years to 70 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Primary Hypercholesterolemia
Interventions: P-OM3, Placebo; Drug
Lead sponsor: Provident Clinical Research; Other
Eligibility: 18 Years to 79 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: Addison, Illinois

Conditions: Alzheimer's Disease, Mild Cognitive Impairment
Interventions: Gastro-retentive zinc cysteine tablet, Tablet identical physically to active comparator containing some lactose; Other
Lead sponsor: Adeona Pharmaceuticals; Industry
Eligibility: 55 Years to 90 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 3
States / cities: Clearwater, Florida • Holiday, Florida • Port Richey, Florida

Conditions: Type 2 Diabetes Mellitus
Interventions: 10-week exercise program on HA accumulation; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 40 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Type 2 Diabetes Mellitus, Hypertension
Interventions: Placebo, Sitagliptin, Aprepitant, Mixed Meal Test (MMT); Drug · Other
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Hyperlipidemia
Interventions: Vitamin D3, Placebo; Dietary Supplement · Other
Lead sponsor: Avera McKennan Hospital & University Health Center; Other
Eligibility: 18 Years to 88 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Diabetes Mellitus, Type 2
Interventions: LY2189265, Sitagliptin; Biological · Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 3
States / cities: Daytona Beach, Florida • Honolulu, Hawaii • Dallas, Texas

Conditions: Obesity & Overweight, Type 2 Diabetes, Type 2 Diabetes (Adult Onset), Obesity Type 2 Diabetes Mellitus, Dehydration
Interventions: Hydration Plus, Control; Behavioral
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years to 60 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Obesity, Protein-energy; Imbalance, Insulin Sensitivity, Gastrointestinal Complication
Interventions: Laparoscopic Roux-en-Y gastric bypass, Laparoscopic gastric banding, Laparoscopic sleeve gastrectomy, Low Calorie Diet; Procedure · Behavioral
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Diabetes Mellitus
Interventions: Insulin Detemir, Insulin Glargine; Drug
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years to 60 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Aging, Alcohol Drinking
Interventions: Visbiome, Motivational Interviewing, Placebo; Dietary Supplement · Behavioral · Other
Lead sponsor: University of Miami; Other
Eligibility: 65 Years to 84 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Cardiovascular Disease, Diabetes, Metabolic Syndrome
Interventions: Soybean oil, High-oleic soybean oil, High-oleic soybean oil + fully hydrogenated soybean oil, Palm olein + palm stearin; Other
Lead sponsor: USDA Beltsville Human Nutrition Research Center; Federal
Eligibility: 30 Years to 70 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 1
States / cities: Beltsville, Maryland

Conditions: Obesity, Childhood, Antibiotic Side Effect
Interventions: Not listed
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: Up to 96 Hours
Enrollment: 509 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Seizures
Interventions: Ketogenic Therapy; Dietary Supplement
Lead sponsor: University of Florida; Other
Eligibility: Up to 50 Years
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2031
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Metabolic Syndrome
Interventions: Berberine, Identical Placebo; Dietary Supplement · Other
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Cardiovascular Disease, Vitamin D Deficiency
Interventions: Vitamin D3, Placebo; Dietary Supplement
Lead sponsor: Intermountain Health Care, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Murray, Utah

Conditions: Diabetes Mellitus, Type 2
Interventions: BMS-823778, Placebo, Metformin; Drug
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 3
States / cities: Hialeah, Florida • Olympia, Washington • Milwaukee, Wisconsin

Conditions: Atherosclerotic Cardiovascular Disease
Interventions: Inclisiran; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 43
States / cities: Little Rock, Arkansas • Los Angeles, California • Greenwich, Connecticut + 32 more

Conditions: Hyperkalemia
Interventions: Patiromer; Drug
Lead sponsor: Vifor Pharma, Inc.; Industry
Eligibility: 2 Years to 17 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 10
States / cities: Palo Alto, California • Kansas City, Kansas • Baltimore, Maryland + 7 more

Conditions: Hyperparathyroidism
Interventions: Alendronate 70mg weekly; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: New York, New York

Conditions: HIV Infections, HIV Seronegativity, Lipodystrophy
Interventions: Pravastatin sodium, Simvastatin, Atorvastatin calcium, Nelfinavir mesylate, Efavirenz; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 60 Years
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
U.S. locations: 10
States / cities: Stanford, California • Denver, Colorado • Baltimore, Maryland + 6 more

Search by objective public record fields.

Short-term Sugary Beverage Consumption on Glucose Control and Cardiovascular Disease Risk Factors

A Single-arm Evaluation of the Effect of HCV Treatment on Cardiovascular Disease Risk

Effects of AZD5004 in Adults Who Are Living With Obesity or Overweight With at Least 1 Weight-related Comorbidity

Effects of L-Carnitine on Postprandial Clearance of Triglyceride-rich Lipoproteins in HIV Patients on HAART

Effects of Prescription Omega-3 on LDL-C in Primary Hypercholesterolemia

Trial of Novel Oral Zinc Cysteine Preparation in Alzheimer's Disease

Targeting Hyaluronan Accumulation Through Exercise in T2DM

Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure

A Pilot Study on the Effect of Vitamin D Treatment in Patients With Statin-Associated Myalgia

A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes

Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy

Bariatric Surgery and Weight Loss on Energy Metabolism and Insulin Sensitivity

Insulin Detemir Compared to Insulin Glargine: Appetite and Calories Consumed in Type 1 Diabetes

The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers

Soybean Oil Trial of cArdiovascular Risk

Microbiome, Antibiotics, and Growth Infant Cohort

Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

Evaluating the Tolerability and Effects of Berberine on Major Metabolic Biomarkers: A Pilot Study

Acute Effect of Systemic Stress on Measured Blood Concentrations of 25 (OH) Vitamin D

Safety Study of BMS-823778 in Subjects With Type 2 Diabetes

A Randomized Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTORION-INITIATE)

Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia

The Effects of Alendronate After Cure of Primary Hyperparathyroidism

The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs